These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

984 related items for PubMed ID: 29599331

  • 1. Isochlorogenic Acid C Reverses Epithelial-Mesenchymal Transition via Down-regulation of EGFR Pathway in MDA-MB-231 cells.
    Yu JK, Yue CH, Pan YR, Chiu YW, Liu JY, Lin KI, Lee CJ.
    Anticancer Res; 2018 Apr; 38(4):2127-2135. PubMed ID: 29599331
    [Abstract] [Full Text] [Related]

  • 2. [Inhibition of Histone Deacetylases Reverses Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer Cells through a Slug Mediated Mechanism].
    Rahimian A, Barati G, Mehrandish R, Mellati AA.
    Mol Biol (Mosk); 2018 Apr; 52(3):474-481. PubMed ID: 29989579
    [Abstract] [Full Text] [Related]

  • 3. Inhibiting epidermal growth factor receptor signalling potentiates mesenchymal-epithelial transition of breast cancer stem cells and their responsiveness to anticancer drugs.
    Manupati K, Dhoke NR, Debnath T, Yeeravalli R, Guguloth K, Saeidpour S, De UC, Debnath S, Das A.
    FEBS J; 2017 Jun; 284(12):1830-1854. PubMed ID: 28398698
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of SK4 Potassium Channels Suppresses Cell Proliferation, Migration and the Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer Cells.
    Zhang P, Yang X, Yin Q, Yi J, Shen W, Zhao L, Zhu Z, Liu J.
    PLoS One; 2016 Jun; 11(4):e0154471. PubMed ID: 27124117
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Suppression of Spry1 inhibits triple-negative breast cancer malignancy by decreasing EGF/EGFR mediated mesenchymal phenotype.
    He Q, Jing H, Liaw L, Gower L, Vary C, Hua S, Yang X.
    Sci Rep; 2016 Mar 15; 6():23216. PubMed ID: 26976794
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.
    Xu J, Zhang X, Wang H, Ge S, Gao T, Song L, Wang X, Li H, Qin Y, Zhang Z.
    Biomed Pharmacother; 2017 Apr 15; 88():421-429. PubMed ID: 28122307
    [Abstract] [Full Text] [Related]

  • 10. Ginsenoside 20(S)-protopanaxadiol inhibits triple-negative breast cancer metastasis in vivo by targeting EGFR-mediated MAPK pathway.
    Peng B, He R, Xu Q, Yang Y, Hu Q, Hou H, Liu X, Li J.
    Pharmacol Res; 2019 Apr 15; 142():1-13. PubMed ID: 30735802
    [Abstract] [Full Text] [Related]

  • 11. Doxorubicin-Resistant TNBC Cells Exhibit Rapid Growth with Cancer Stem Cell-like Properties and EMT Phenotype, Which Can Be Transferred to Parental Cells through Autocrine Signaling.
    Paramanantham A, Jung EJ, Kim HJ, Jeong BK, Jung JM, Kim GS, Chan HS, Lee WS.
    Int J Mol Sci; 2021 Nov 18; 22(22):. PubMed ID: 34830320
    [Abstract] [Full Text] [Related]

  • 12. Umbilical cord-derived mesenchymal stem cells promote proliferation and migration in MCF-7 and MDA-MB-231 breast cancer cells through activation of the ERK pathway.
    Li T, Zhang C, Ding Y, Zhai W, Liu K, Bu F, Tu T, Sun L, Zhu W, Zhou F, Qi W, Hu J, Chen H, Sun X.
    Oncol Rep; 2015 Sep 18; 34(3):1469-77. PubMed ID: 26151310
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition.
    Su CM, Lee WH, Wu AT, Lin YK, Wang LS, Wu CH, Yeh CT.
    J Nutr Biochem; 2015 Jun 18; 26(6):675-85. PubMed ID: 25792283
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Tamoxifen reverses epithelial-mesenchymal transition by demethylating miR-200c in triple-negative breast cancer cells.
    Wang Q, Cheng Y, Wang Y, Fan Y, Li C, Zhang Y, Wang Y, Dong Q, Ma Y, Teng YE, Qu X, Liu Y.
    BMC Cancer; 2017 Jul 19; 17(1):492. PubMed ID: 28724364
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of ERRα suppresses epithelial mesenchymal transition of triple negative breast cancer cells by directly targeting fibronectin.
    Wu YM, Chen ZJ, Liu H, Wei WD, Lu LL, Yang XL, Liang WT, Liu T, Liu HL, Du J, Wang HS.
    Oncotarget; 2015 Sep 22; 6(28):25588-601. PubMed ID: 26160845
    [Abstract] [Full Text] [Related]

  • 19. Myeloid Zinc Finger 1 (MZF1) Maintains the Mesenchymal Phenotype by Down-regulating IGF1R/p38 MAPK/ERα Signaling Pathway in High-level MZF1-expressing TNBC cells.
    Yue CH, Liu JY, Chi CS, Hu CW, Tan KT, Huang FM, Pan YR, Lin KI, Lee CJ.
    Anticancer Res; 2019 Aug 22; 39(8):4149-4164. PubMed ID: 31366500
    [Abstract] [Full Text] [Related]

  • 20. Chrysin inhibits metastatic potential of human triple-negative breast cancer cells by modulating matrix metalloproteinase-10, epithelial to mesenchymal transition, and PI3K/Akt signaling pathway.
    Yang B, Huang J, Xiang T, Yin X, Luo X, Huang J, Luo F, Li H, Li H, Ren G.
    J Appl Toxicol; 2014 Jan 22; 34(1):105-12. PubMed ID: 24122885
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.